Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003403207 | SCV004111216 | likely pathogenic | DYNC2H1-related disorder | 2023-02-01 | criteria provided, single submitter | clinical testing | The DYNC2H1 c.7577T>G variant is predicted to result in the amino acid substitution p.Ile2526Ser. This variant has been reported in fetuses affected with short rib-polydactyly syndrome (Ellard et al 2015. PubMed ID: 24961629; Table S2 in Zhang W et al 2017. PubMed ID: 29068549). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Based on the available evidence, this variant is interpreted as likely pathogenic. |
Fulgent Genetics, |
RCV001291179 | SCV005678331 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-05-31 | criteria provided, single submitter | clinical testing | |
Dan Cohn Lab, |
RCV001291179 | SCV000611960 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291179 | SCV001479602 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research |